CCIF:NYSE
Carlyle Credit Income Fund
ā§§.ā§Ŧā§Ļ US$
arrow_downward
-ā§Š.ā§Šā§¨%(-ā§Ļ.ā§Ļā§Ģā§Ģ) ā§§ āĻĻāĻŋ
ā§§ā§¨ āĻ¨āĻā§, ā§§:ā§¨ā§¨:ā§Ēā§Ž PM GMT -ā§Ģ · USD
search
āĻ¸āĻŦ āĻ¸āĻŋāĻŽā§āĻŦāĻ˛
| āĻ¸āĻŋāĻŽā§āĻŦāĻ˛ | āĻĻāĻžāĻŽ | āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ āĻāĻ°ā§āĻ¨ | % āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|
āĻāĻ āĻ§āĻ°āĻ¨ā§āĻ° āĻāĻ°āĻ āĻ
ā§āĻ¯āĻžāĻ¸ā§āĻ
āĻāĻŦāĻ°ā§āĻ° āĻ¸ā§āĻā§āĻ°āĻŋ
āĻā§ā§āĻŦ āĻ¸ā§āĻ°ā§āĻ¸ āĻ āĻāĻŦāĻ°ā§āĻ° āĻĒāĻžāĻ°ā§āĻāĻ¨āĻžāĻ°āĻĻā§āĻ° āĻĨā§āĻā§
FinancialContent
·
ā§Ēā§¯ āĻŽāĻŋāĻ¨āĻŋāĻ āĻāĻā§
Kaplan Fox Notifies Investors of Millrose Properties, Inc. (NYSE: MRP) of the Lead Plaintiff Deadline on December 8, 2026
kalkine.ca
·
ā§§ā§Š āĻŽāĻŋāĻ¨āĻŋāĻ āĻāĻā§
Top 4 Immunology and Neuroscience Biotech Names Due on November 13, 2026: Eledon Pharmaceuticals (NASDAQ:ELDN) EPS Estimate -0.19, Immunic, Inc. (NASDAQ:IMUX) EPS Estimate -0.95, Neumora Therapeutics (NASDAQ:NMRA) EPS Estimate -0.
Barron's
·
ā§Ž āĻŽāĻŋāĻ¨āĻŋāĻ āĻāĻā§
You Donât Need Nvidia to Beat the S&P 500. These ETFs Prove It.
Yahoo Finance
·
ā§Ģā§Ē āĻŽāĻŋāĻ¨āĻŋāĻ āĻāĻā§
3 Unstoppable Dow Stocks to Buy in November and Hold for the Next Decade